Instituto Palacios   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Madrid Spain (1990)

Organization Overview

First Clinical Trial
2004
NCT00235924
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dr. Santiago Palacios | Instituto Palacios | Instituto Palacios, Madrid, SPAIN

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 3)

Hot Flashes (Phase 4)

Hypocalcemia (Phase 3)

Osteoporosis (Phase 4)

Osteoporosis, Postmenopausal (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 9